Global Market for Arthroscopy Products and Sports Medicine Implants (2019)
Global Market for Arthroscopy Products and Sports Medicine Implants (2019)
$4,750.00
This Meddevicetracker report provides an analysis of the market for arthroscopy products (including visualization systems, fluid management equipment, and manual and powered instruments) and sports medicine/soft tissue fixation implants for the US, five major EU markets, Japan, and the rest of the world.
Publisher: Meddevicetracker
- Highlights
- Description
- Contents
Key Questions Answered:
- What are the key drivers of the markets for arthroscopy products and sports medicine implants?
- Which competitors are leading the markets and introducing new technology?
- How are technological advancements impacting market growth?
- Which areas of the market are experiencing dynamic growth?
- How are mergers, acquisitions, and divestitures affecting the market shares?
Market Insights:
- Approximately 6.8 million arthroscopy procedures were performed worldwide in 2018, with knee arthroscopy accounting for the largest share.
- The combined global market for arthroscopy products and sports medicine implants totaled approximately $7.3bn in 2018, and is expected to climb at a CAGR of 4.2% over the forecast period covered by this analysis.
- Within the combined market, arthroscopy products accounted for approximately 51.9% of sales.
- Leading competitors in the market for arthroscopy products and sports medicine implants include Arthrex, DePuy Synthes/ Johnson & Johnson, Smith & Nephew, and Stryker.
Overview
This medical market and technology report provides a comprehensive discussion of the global market for arthroscopy products and sports medicine implants. Geographic markets covered by this analysis include the US, Japan, five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW), which includes all other countries.
This report provides the following useful information:
- a clinical overview of arthroscopic surgery
- sports injury incidence data
- arthroscopy procedure volumes
- product portfolios offered by leading manufacturers and emerging companies
- in-depth market and competitive analyses.
Table of Contents
Executive Summary…………………………………………………………………………………………………………….ES-1
i. Market analysis…………………………………………………………………………………………………………ES-1
a. Selected market drivers and limiters…………………………………………………………ES-5
b. Market leaders……………………………………………………………………………………….ES-5
ii. Methodology …………………………………………………………………………………………………………..ES-5
Exhibit ES-1: Bone densitometry systems and bone turnover marker tests, combined market forecast, by segment ($m), 2017-23………………………………………..ES-2
Exhibit ES-2: Bone densitometry systems and bone turnover marker tests, combined market forecast, by region ($m), 2017-23……………………………………………ES-4
1. Overview of Osteoporosis………………………………………………………………………………………………… 1-1
1.1 Prevalence …………………………………………………………………………………………………………….. 1-1
1.2 Fracture incidence and economic costs…………………………………………………………………….. 1-2
1.3 Types of osteoporosis……………………………………………………………………………………………… 1-5
1.4 Risk factors…………………………………………………………………………………………………………….. 1-6
1.5 Treatment……………………………………………………………………………………………………………… 1-9
1.6 Bibliography…………………………………………………………………………………………………………. 1-11
Exhibit 1-1: Osteoporosis prevalence rate, per 10,000 population, US ……………………………………. 1-1
Exhibit 1-2: Osteoporosis prevalence, five major EU markets ………………………………………………… 1-2
Exhibit 1-3: Osteoporosis prevalence, Japan………………………………………………………………………… 1-2
Exhibit 1-4: Osteoporosis-caused fracture incidence in the EU, by fracture site ……………………….. 1-3
Exhibit 1-5: Number of visits for osteoporotic fractures (in 000s), US……………………………………… 1-4
Exhibit 1-6: Types of osteoporosis and their primary causes and fracture types ………………………. 1-5
Exhibit 1-7: Leading risk factors for osteoporosis………………………………………………………………….. 1-6
Exhibit 1-8: Population growth of 65+ years age group, selected countries, 2000-50………………… 1-7
2. Bone Densitometry Products Market ……………………………………………………………………………….. 2-1
2.1 Bone densitometry overview …………………………………………………………………………………… 2-1
2.1.1 Dual-energy X-ray absorptiometry……………………………………………….. 2-3
2.1.2 Single-energy X-ray absorptiometry …………………………………………….. 2-4
2.1.3 Radiographic absorptiometry………………………………………………………. 2-4
2.1.4 Quantitative computed tomography ……………………………………………. 2-4
2.1.5 Quantitative ultrasound……………………………………………………………… 2-4
2.1.6 Software-based densitometry systems…………………………………………. 2-5
2.1.7 Hospital-based densitometry systems………………………………………….. 2-6
2.1.8 Office-based densitometry systems……………………………………………… 2-6
2.2 Densitometry products……………………………………………………………………………………………. 2-6
2.2.1 BeamMed…………………………………………………………………………………. 2-7
2.2.2 CompuMed……………………………………………………………………………….. 2-7
2.2.3 Furuno Electric Company ……………………………………………………………. 2-8
2.2.4 GE Healthcare/General Electric Company …………………………………….. 2-8
2.2.5 Hologic……………………………………………………………………………………… 2-8
2.2.6 Swissray……………………………………………………………………………………. 2-8
2.2.7 Emerging company…………………………………………………………………… 2-12
2.3 Market analysis…………………………………………………………………………………………………….. 2-12
2.3.1 Market forecast: US………………………………………………………………….. 2-15
2.3.2 Market forecast: EU …………………………………………………………………. 2-18
2.3.3 Market forecast: Japan……………………………………………………………… 2-19
2.3.4 Market forecast: rest of the world……………………………………………… 2-20
2.3.5 Competitive analysis: global………………………………………………………. 2-21
2.4 Primary research…………………………………………………………………………………………………… 2-26
2.5 Bibliography…………………………………………………………………………………………………………. 2-29
Exhibit 2-1: Comparison of biochemical markers and bone densitometry for diagnosing and monitoring osteoporosis…………………………………………………………………………….. 2-2
Exhibit 2-2: Imaging modalities used to diagnose osteoporosis ……………………………………………… 2-5
Exhibit 2-3: Selected bone densitometry systems…………………………………………………………………. 2-9
Exhibit 2-4: DXA price range, US……………………………………………………………………………………….. 2-11
Exhibit 2-5: The Lunar iDXA dual-energy X-ray absorptiometry system………………………………….. 2-11
Exhibit 2-6: The Horizon dual-energy X-ray absorptiometry system………………………………………. 2-12
Exhibit 2-7: Bone densitometry systems market forecast, by region, 2017-23 ……………………….. 2-14
Exhibit 2-8: Bone densitometry systems global market, share by supplier, 2017…………………….. 2-21
Exhibit 2-9: Bone densitometry systems US market, share by supplier, 2017…………………………. 2-23
Exhibit 2-10: Bone densitometry systems five major EU markets, share by supplier, 2017 ………… 2-24
Exhibit 2-11: Bone densitometry systems Japan market, share by supplier, 2017 …………………….. 2-25
Exhibit 2-12: Bone densitometry systems RoW market, share by supplier, 2017………………………. 2-26
Exhibit 2-13: Meddevicetracker survey: percentage of bone density scans performed to screen for osteoporosis, 2018……………………………………………………………………… 2-26
Exhibit 2-14: Meddevicetracker survey: How did the number of bone density scans you performed or referred in 2018 compare to 2017?……………………………………………… 2-27
Exhibit 2-15: Meddevicetracker survey: type of bone densitometry system used, as a percentage of total bone scans…………………………………………………………………. 2-28
3. Market for Bone Turnover Marker Tests……………………………………………………………………………. 3-1
3.1 Biochemical markers overview…………………………………………………………………………………. 3-1
3.1.1 Types of bone turnover markers………………………………………………….. 3-2
3.1.2 Applications………………………………………………………………………………. 3-5
3.1.3 Limitations………………………………………………………………………………… 3-5
3.2 Bone turnover marker testing products…………………………………………………………………….. 3-6
3.2.1 Alere/Abbott …………………………………………………………………………….. 3-6
3.2.2 Beckman Coulter/Danaher………………………………………………………….. 3-6
3.2.3 Immunodiagnostic Systems ………………………………………………………… 3-6
3.2.4 Orion Diagnostica/Orion Group …………………………………………………… 3-7
3.2.5 Quest Diagnostics………………………………………………………………………. 3-7
3.2.6 Quidel ………………………………………………………………………………………. 3-7
3.2.7 Roche Diagnostics/F. Hoffmann-La Roche …………………………………….. 3-7
3.3 Reimbursement……………………………………………………………………………………………………… 3-9
3.4 Market analysis………………………………………………………………………………………………………. 3-9
3.5 Competitive analysis……………………………………………………………………………………………… 3-12
3.6 Primary research…………………………………………………………………………………………………… 3-12
3.7 Bibliography…………………………………………………………………………………………………………. 3-14
Exhibit 3-1: The bone remodeling cycle……………………………………………………………………………….. 3-2
Exhibit 3-2: Comparison of the types of bone turnover marker tests………………………………………. 3-3
Exhibit 3-3: Selected bone turnover marker tests…………………………………………………………………. 3-8
Exhibit 3-4: Bone turnover marker tests market forecast, by region, 2017-23………………………… 3-11
Exhibit 3-5: Bone turnover marker tests global market, share by supplier, 2017…………………….. 3-12
Exhibit 3-6: Meddevicetracker survey: How effective do you consider bone turnover marker tests for identifying patients at high risk of osteoporosis? ………………………………….. 3-13
Exhibit 3-7: Meddevicetracker survey: How effective do you consider bone turnover marker tests for monitoring treatment for osteoporosis? ……………………………………………… 3-13
APPENDIX: COMPANY LISTING……………………………………………………………………………………………………..A-1
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Gene Therapy Pipeline and Portfolio Analysis 
Sign up to the